Jeffrey M Nugent's Net Worth

$1.2 Million

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Jeffrey M Nugent?

Jeffrey M Nugent has an estimated net worth of $1.2 Million. This is based on reported shares across multiple companies, which include BIOFORM MEDICAL INC, Sientra, Inc., BIOLASE, INC, and Neothetics, Inc..

SEC CIK

Jeffrey M Nugent's CIK is 0001455940

Past Insider Trading and Trends

2014 was Jeffrey M Nugent's most active year for acquiring shares with 5 total transactions. Jeffrey M Nugent's most active month to acquire stocks was the month of May. 2019 was Jeffrey M Nugent's most active year for disposing of shares, totalling 4 transactions. Jeffrey M Nugent's most active month to dispose stocks was the month of January. 2014 saw Jeffrey M Nugent paying a total of $199,998.46 for 329,011 shares, this is the most they've acquired in one year. In 2020 Jeffrey M Nugent cashed out on 142,891 shares for a total of $814,914.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOFORM MEDICAL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Dec 10
Form 3
—
0
—
—
0
No matching records found

Sientra, Inc. (SIEN) No price found

Chairman the Board and CEO

Jeffrey M Nugent owns 200,511 units of Common Stock, 197,993 units of Common Stock (RSU) and 343,971 units of Common Stock (RSUs). In the year 2014 Jeffrey M Nugent acquired a total of 385,345 shares in Sientra, Inc. at a cost of $25,002.00, Jeffrey also disposed a total of 184,834 shares of Sientra, Inc. equalling to $1,412,451.49.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.44%
-9.31K
$2.52
-$23,473.80
200.51K
May 1
Form 4
-38.90%
-133.58K
$5.93
-$791,440.40
209.83K
Scheduled
Feb 18 - Feb 20
Form 4
-0.17%
-569.00
$6.65
-$3,783.85
343.4K
May 13
Form 4
+24.41%
67.5K
—
—
343.97K
Apr 5
Form 4
-0.14%
-382.00
$10.66
-$4,072.12
276.47K
Feb 12
Form 4
-4.60%
-13.36K
$12.35
-$165,008.35
276.85K
Jan 22
Form 4
-2.49%
-7.40K
$13.64
-$100,881.44
290.21K
Jan 2
Form 4
-0.13%
-389.00
$17.61
-$6,850.29
297.61K
Nov 12
Form 4
-0.62%
-1.85K
$24.90
-$46,114.80
298K
Aug 31
Form 4
+0.62%
1.85K
$13.50
$25,002.00
299.85K
May 7
Form 4
+65.56%
118K
—
—
298K
Jan 19
Form 4
-4.27%
-8.03K
$14.27
-$114,559.56
180K
Jan 2
Form 4
-5.03%
-9.97K
$15.68
-$156,266.88
188.03K
Oct 17
Form 4
+1,000.39%
180K
—
—
197.99K
Apr 12
Form 4
—
0
—
—
0
Jan 1
Form 4
∞
17.99K
—
—
17.99K
Nov 12
Form 4
—
0
—
—
0
Jun 26
Form 3
—
0
—
—
0
No matching records found

BIOLASE, INC (BIOL) Snapshot price: $0.05425

Chief Executive Officer

Jeffrey M Nugent owns 52,083 units of Common Stock, par value $0.001 per share which is worth $2,825.50 and 92,548 units of Common Stock which is worth $5,020.73. In the year 2014 Jeffrey M Nugent filed a total of 4 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+77.69%
40.47K
$2.39
$96,711.35
92.55K
Nov 3
Form 4
∞
52.08K
$1.92
$99,999.36
52.08K
Jul 22
Form 4
—
0
—
—
0
Jul 13
Form 3
—
0
—
—
0
No matching records found

Neothetics, Inc. (EVFM) Snapshot price: $0.0099

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Sep 23
Form 3
—
0
—
—
0
No matching records found